Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Head & Neck Oncology
Published in: Head & Neck Oncology 1/2011

Open Access 01-12-2011 | Research

Prognostic significance of heat shock protein 70 (HSP70) in patients with oral cancer

Authors: Frank Tavassol, Oliver F Starke, Horst Kokemüller, Gerd Wegener, Corinna CM Müller-Tavassol, Nils-Claudius Gellrich, André Eckardt

Published in: Head & Neck Oncology | Issue 1/2011

Login to get access

Abstract

Backround

Oral squamous cell carcinoma (OSCC) is characterized by an aggressive growth pattern, local invasiveness, and spread to cervical lymph nodes. Overall survival rates have not improved, primarily due to locoregional tumor recurrences and distant metastasis. To date, no trustworthy or clinically applicable marker of tumor aggressiveness has been identified for OSCC. Heat shock proteins (HSPs) play a role in tumor antigenicity. This study aimed to investigate the expression and prognostic significance of highly stress-inducible HSP70 in OSCC.

Methods

Immunohistochemical staining for HSP70 was performed on surgical specimens obtained from 61 patients with OSCC. Light microscopy and analysis 3.1® (Soft Imaging System, Münster, Germany), an image processing and analysis program, were used for evaluating HSP70 expression. The tumor region was defined as the region of interest (ROI) and HSP70-positive staining was analyzed.

Results

Immunoreactivity for HSP70 was positive in tumor cells of 38 of all patients (63.3%). Positive immunoreactivity of tumor cells could be detected in 17 of 28 patients with T2 tumors (60.7%) Prognostic significance of HSP70 expression in tumor cells was detected in patients with T2 tumors (p = 0.009).

Conclusions

The survival of patients suffering from T2 tumors with positive HSP70 expression was 8 times higher than that for patients with negative HSP70 expression, suggesting that T1-T2 tumors of OSCC with low expression of HSP70 require more radical treatment.
Appendix
Available only for authorised users
Literature
1.
Eckardt A, Barth EL, Kokemueller H, Wegener G: Recurrent carcinoma of the head and neck: treatment strategies and survival analysis in a 20-year period. Oral Oncol. 2004, 40: 427-432. 10.1016/j.oraloncology.2003.09.019.CrossRefPubMed
2.
Kokemüller H, Brachvogel P, Eckardt A, Hausamen JE: Effectiveness of neck dissection in metastasizing mouth carcinoma. Uni- and multivariate analysis of factors of influence. Mund Kiefer Gesichtschir. 2002, 6 (2): 91-7.CrossRefPubMed
3.
Shah NG, Trivedi TI, Tankshali RA, Goswami JV, Jetly DH, Shukla SN, et al: Prognostic significance of molecular markers in oral squamous cell carcinoma: a multivariate analysis. Head Neck. 2009, 31 (12): 1544-56. 10.1002/hed.21126.CrossRefPubMed
4.
Fourati A, El May MV, Ben Abdallah M, Gamoudi A, Mokni N, Goucha A, Boussen H, Ladgham A, El May A: Prognostic evaluation of p53, heat shock protein 70, Ki67, and CD34 expression in Cancer of the tongue in Tunisia. J Otolaryngol Head Neck Surg. 2009, 38 (2): 191-6.PubMed
5.
Gandour-Edwards R, Trock BJ, Gumerlock P, Donald PJ: Heat shock protein and p53 expression in head and neck squamous cell carcinoma. J Otolaryngol Head Neck Surg. 1998, 118 (5): 610-5.
6.
Tavassol F, Starke OF, Völker B, Kokemüller H, Eckardt A: Heat-shock protein expression and topical treatment with tacrolimus in oral lichen planus: an immunohistochemical study. Int J Oral Maxillofac Surg. 2008, 37 (1): 66-9. 10.1016/j.ijom.2007.06.016.CrossRefPubMed
7.
Morimoto RI, Tisseres A, Georgopolous C: Stress proteins in biology and medicine. 1990, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press
8.
Morimoto RI: Cells in stress: transcriptional activation of heat shock genes. Science. 1993, 259: 1409-10. 10.1126/science.8451637.CrossRefPubMed
9.
Ciocca DR, Adams DJ, Edwards DP, Bjercke RJ, McGuire WL: Distribution of an estrogen-induced protein with a molecular weight of 24,000 in normal and malignant human tissues and cells. Cancer Res. 1983, 43: 1204-10.PubMed
10.
Ferrarini M, Helatai S, Zocchi MR, Rugarli C: Unusual expression and localization of heat-shock proteins in human tumor cells. Int J Cancer. 1992, 51: 613-9. 10.1002/ijc.2910510418.CrossRefPubMed
11.
Lazaris AC, Theodorpoulos GE, Davaris PS, Panoussopoulos P, Nakopoulos L, Kittas C, Golematis BC: Heat shock protein 70 and HLA-DR molecules tissue expression: prognostic implication in colorectal cancer. Dis Colon Rectum. 1995, 38: 739-745. 10.1007/BF02048033.CrossRefPubMed
12.
Lazaris AC, Chatzigianni EB, Panoussopoulos D, Tzimas GN, Davaris PS, Golematis BC: Proliferating cell nuclear antigen and heat shock protein 70 immunolocalization in invasive ductal breast cancer not otherwise specified. Breast Cancer Res Treat. 1997, 43: 43-51. 10.1023/A:1005706110275.CrossRefPubMed
13.
Santarosa M, Favaro D, Quaia M, Galligioni E: Expression of heat shock protein 72 in renal call carcinoma: possible role and prognostic implications in cancer patients. Eur J Cancer. 1997, 33: 873-877. 10.1016/S0959-8049(97)00002-6.CrossRefPubMed
14.
Ullrich SJ, Robinson EA, Law LW, Willingham M, Appella E: A mouse tumor-specific transplantation antigen is a heat shockrelated protein. Proc Nat Acad Sci USA. 1986, 83: 3121-3125. 10.1073/pnas.83.10.3121.PubMedCentralCrossRefPubMed
15.
Konno A, Sato N, Yagihashi A, et al: Heat- or stress-inducible transformation-associated cell surface antigen on the activated H-ras oncogene-transfected rat fibroblast. Cancer Res. 1989, 49: 6578-6582.PubMed
16.
Nakajima M, Kuwano H, Miyazaki T, Masuda N, Kato H: Significant correlation between expression of heat shock proteins 27, 70 and lymphocyte infiltration in esophageal squamous cell carcinoma. Cancer Letters. 2002, 178: 99-106. 10.1016/S0304-3835(01)00825-4.CrossRefPubMed
17.
Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc. 1958, 53: 457-8. 10.2307/2281868.CrossRef
18.
Cox DR: Regression models and life tables. J R Stat Soc B. 1972, 34: 187-220.
19.
Lindquist S, Craig EA: The heat-shock proteins. Annu Rev Genet. 1988, 22: 631-77. 10.1146/annurev.ge.22.120188.003215.CrossRefPubMed
20.
Tomei LD, Cope OF, editors: Apoptosis: the molecular basis of cell death. 1991, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press
21.
Ciocca DR, Clark GM, Tandon AK, Fuqua SAW, Welch WJ, McGuire WL: Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications. J Nat Cancer Inst. 1993, 7: 570-57.CrossRef
22.
Takahashi S, Mikami T, Watanabe Y, et al: Correlation of heat shock protein 70 expression with estrogen receptor levels in invasive human breast cancer. Am J Clin Path01. 1994, 101: 519-525.
23.
Santarosa M, Favaro D, Quaia M, Galligioni G: Expression of Heat Shock Protein 72 in Renal Cell Carcinoma: Possible Role and Prognostic Implications in Cancer Patients. EurJ Cancer. 1997, 33 (6): 873-877. 10.1016/S0959-8049(97)00002-6.CrossRef
24.
Fuller KJ, Issels RD, Slosman DO, Guillet JG, Soussi T, Polla BS: Cancer and the heat shock response. Eur J Cancer. 1994, 30A: 1884-1891. 10.1016/0959-8049(94)00362-9.CrossRefPubMed
25.
Kawanishi K, Shiozaki H, Doki Y, Sakita I, Inoue M, Yano M, Tsujinaka T, Shamma A, Monden M: Prognostic significance of heat shock proteins 27 and 70 in patients with squamous cell carcinoma of the esophagus. Cancer. 1999, 85 (8): 1649-57. 10.1002/(SICI)1097-0142(19990415)85:8<1649::AID-CNCR2>3.0.CO;2-V.CrossRefPubMed
26.
Sugerman PB, Savage NW, Xu LJ, Walsh LJ, Seymour GJ: Heat shock protein expression in oral epithelial dysplasia and squamous cell carcinoma. Oral Oncol. 2004, 40 (4): 427-32. 10.1016/j.oraloncology.2003.09.019.CrossRef
27.
Ito T, Kawabe R, Kurasono Y, Hara M, Kitamura H, Fujita K, Kanisawa M: Expression of heat shock proteins in squamous cell carcinoma of the tongue: an immunohistochemical study. J Oral Pathol Med. 1998, 27 (1): 18-22. 10.1111/j.1600-0714.1998.tb02085.x.CrossRefPubMed
28.
Kleinjung T, Arndt O, Feldmann HJ, Bockmühl U, Gehrmann M, Zilch T, Pfister K, Schönberger J, Marienhagen J, Eilles C, Rossbacher L, Multhoff G: Heat shock protein 70 (Hsp70) membrane expression on head-and-neck cancer biopsy-a target for natural killer (NK) cells. Int J Radiat Oncol Biol Phys. 2003, 57 (3): 820-6. 10.1016/S0360-3016(03)00629-1.CrossRefPubMed
Metadata
Title
Prognostic significance of heat shock protein 70 (HSP70) in patients with oral cancer
Authors
Frank Tavassol
Oliver F Starke
Horst Kokemüller
Gerd Wegener
Corinna CM Müller-Tavassol
Nils-Claudius Gellrich
André Eckardt
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Head & Neck Oncology / Issue 1/2011
Electronic ISSN: 1758-3284
DOI
https://doi.org/10.1186/1758-3284-3-10

Other articles of this Issue 1/2011

Head & Neck Oncology 1/2011 Go to the issue

Case report

Orbital metastases as first sign of metastatic spread in breast cancer: Case report and review of the literature

Review

A case report of metastasis of malignant mesothelioma to the oral gingiva

Review

How to do it: the difficult thyroid

Case report

Myxolipoma in the tongue - A clinical case report and review of the literature

Research

The submental flap for oral cavity reconstruction: Extended indications and technical refinements

Research

Evaluation of white blood cell count as a possible prognostic marker for oral cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits